Company Data
Tourmaline Bio Inc.
Ticker
TRML
Current Price
$13.805 -0.18%
Market Cap
$354.0M
Price Target
Refer to Report
Volume
115.6K
52wk Range
$12.12 - $48.31
Overview
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.